The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy
Abstract
The clinical effects of glatiramer acetate (GA), an approved therapy for multiple sclerosis, are thought to be largely mediated by a T-helper 1 (TH1) to T-helper 2 (TH2) shift of GA-reactive T-lymphocytes. Current theories propose that activated GA-reactive TH2 cells penetrate the CNS, release anti-inflammatory cytokines such as interleukin (IL)-4, IL-5 and IL-10, and thus inhibit neighbouring inflammatory cells by a mechanism termed 'bystander suppression'. We demonstrate that both GA-specific TH2 and TH1 cells produce the neurotrophin brain-derived neurotrophic factor (BDNF). As the signal-transducing receptor for BDNF, the full-length 145 tyrosine kinase receptor (trk) B, is expressed in multiple sclerosis lesions, it is likely that the BDNF secreted by GA-reactive TH2 and TH1 has neurotrophic effects in the multiple sclerosis target tissue. This may be an additional mechanism of action of GA, and may be relevant for therapies with altered peptide ligands in general. To demonstrate that GA-reactive T cells produce BDNF, we selected four GA-specific, long-term T-cell lines (TCLs), which were characterized according to their cytokine profile by intracellular double-fluorescence flow cytometry. Three TCLs (isolated from a normal subject) had the phenotypes TH1, TH1/TH0, and TH0; the fourth, derived from a GA-treated patient, had the phenotype TH2. To demonstrate BDNF production, we used a combination of RT-PCR (reverse transcription-polymerase chain reaction) and two specially designed techniques for BDNF protein detection: one was based on ELISA (enzyme-linked immunosorbent assay) of supernatants from co-cultures of GA-specific TCLs plus GA-pulsed antigen-presenting cells, and the other on the direct intracellular staining of BDNF in individual T cells and flow cytometric analysis. The different assays and different TCLs yielded similar, consistent results. All four GA-specific T-cell lines, representing the major different TH phenotypes, could be stimulated to produce BDNF.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)
Kurtzke, J. F. (1983) · Neurology · doi:10.1212/wnl.33.11.1444 · Cited by 15,011
The expanding universe of T-cell subsets: Th1, Th2 and more
Mosmann, T. R., & Sad, S. (1996) · Immunology Today · doi:10.1016/0167-5699(96)80606-2 · Cited by 3,633
Physiology of the Neurotrophins
Lewin, G. R., & Barde, Y.-A. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.001445 · Cited by 1,955
Neurotrophins and Neuronal Plasticity
Thoenen, H. (1995) · Science · doi:10.1126/science.270.5236.593 · Cited by 1,927
Lymphocyte responses and cytokines
Paul, W. E., & Seder, R. A. (1994) · Cell · doi:10.1016/0092-8674(94)90332-8 · Cited by 1,828
Kerschensteiner, M., Gallmeier, E., Behrens, L., Leal, V. V., Misgeld, T., Klinkert, W. E. F., Kolbeck, R., Hoppe, E., Oropeza-Wekerle, R.-L., Bartke, I., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.5.865 · Cited by 1,019
Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy
Moalem, G., Leibowitz–Amit, R., Yoles, E., Mor, F., Cohen, I. R., & Schwartz, M. (1999) · Nature Medicine · doi:10.1038/4734 · Cited by 889
Functional Interactions of Neurotrophins and Neurotrophin Receptors
Bothwell, M. (1995) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.18.030195.001255 · Cited by 833
Bielekova, B., Goodwin, B., Richert, N., Cortese, I., Kondo, T., Afshar, G., Gran, B., Eaton, J., Antel, J., Frank, J. A., et al. (2000) · Nature Medicine · doi:10.1038/80516 · Cited by 823
Cellular immune reactivity within the CNS
Wekerle, H., Linington, C., Lassmann, H., & Meyermann, R. (1986) · Trends in Neurosciences · doi:10.1016/0166-2236(86)90077-9 · Cited by 768
Comi, G., Filippi, M., & Wolinsky, J. S. (2001) · PubMed · Cited by 688
Brain-derived neurotrophic factor rescues spinal motor neurons from axotomy-induced cell death
Yan, Q., Elliott, J., & Snider, W. D. (1992) · Nature · doi:10.1038/360753a0 · Cited by 661
Kappos, L., Comi, G., Panitch, H., Oger, J., Antel, J., Conlon, P., Steinman, L., Comi, G., Kappos, L., Oger, J., et al. (2000) · Nature Medicine · doi:10.1038/80525 · Cited by 512
Stadelmann, C., Kerschensteiner, M., Misgeld, T., Brück, W., Hohlfeld, R., & Lassmann, H. (2002) · Brain · doi:10.1093/brain/awf015 · Cited by 425
Duda, P. W., Schmied, M. C., Cook, S. L., Krieger, J. I., & Hafler, D. A. (2000) · Journal of Clinical Investigation · doi:10.1172/jci8970 · Cited by 416
Arrest of Motor Neuron Disease in wobbler Mice Cotreated with CNTF and BDNF
Mitsumoto, H., Ikeda, K., Klinkosz, B., Cedarbaum, J. M., Wong, V., & Lindsay, R. M. (1994) · Science · doi:10.1126/science.8066451 · Cited by 386
Hohlfeld, R. (1997) · Brain · doi:10.1093/brain/120.5.865 · Cited by 365
Leukocyte traffic in the central nervous system: the participants and their roles
Hickey, W. F. (1999) · Seminars in Immunology · doi:10.1006/smim.1999.0168 · Cited by 345
Myelin basic protein‐specific T lymphocyte lines from MS patients and healthy individuals
Pette, M., Fujita, K., Kitze, B., Whitaker, J. N., Albert, E., Kappos, L., & Wekerle, H. (1990) · Neurology · doi:10.1212/wnl.40.11.1770 · Cited by 334
Late Complications of Immune Deviation Therapy in a Nonhuman Primate
Genain, C. P., Abel, K., Belmar, N., Villinger, F., Rosenberg, D. P., Linington, C., Raine, C. S., & Hauser, S. L. (1996) · Science · doi:10.1126/science.274.5295.2054 · Cited by 320
Kipnis, J., Yoles, E., Porat, Z., Cohen, A., Mor, F., Sela, M., Cohen, I. R., & Schwartz, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7446 · Cited by 308
Th1-Th2: Reliable paradigm or dangerous dogma?
Allen, J. E., & Maizels, R. M. (1997) · Immunology Today · doi:10.1016/s0167-5699(97)01102-x · Cited by 306
Neuhaus, O., Farina, C., Yassouridis, A., Wiendl, H., Then Bergh, F., Dose, T., Wekerle, H., & Hohlfeld, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.13.7452 · Cited by 299
Schori, H., Kipnis, J., Yoles, E., WoldeMussie, E., Ruiz, G., Wheeler, L. A., & Schwartz, M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.041609498 · Cited by 286
Aharoni, R., Teitelbaum, D., Sela, M., & Arnon, R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10821 · Cited by 274
Mechanisms of action of glatiramer acetate in multiple sclerosis
Neuhaus, O., Farina, C., Wekerle, H., & Hohlfeld, R. (2001) · Neurology · doi:10.1212/wnl.56.6.702 · Cited by 248
The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis
Hohlfeld, R., Kerschensteiner, M., Stadelmann, C., Lassmann, H., & Wekerle, H. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00233-2 · Cited by 235
Miller, A., Shapiro, S., Gershtein, R., Kinarty, A., Rawashdeh, H., Honigman, S., & Lahat, N. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00191-x · Cited by 225
Steinman, L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2253 · Cited by 220
Aharoni, R., Teitelbaum, D., Leitner, O., Meshorer, A., Sela, M., & Arnon, R. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.21.11472 · Cited by 215
Besser, M., & Wank, R. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6303 · Cited by 214
Aharoni, R., Teitelbaum, D., Sela, M., & Arnon, R. (1998) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(98)00166-0 · Cited by 173
Gravel, C., Götz, R., Lorrain, A., & Sendtner, M. (1997) · Nature Medicine · doi:10.1038/nm0797-765 · Cited by 170
Flügel, A., Matsumuro, K., Neumann, H., Klinkert, W. E. F., Birnbacher, R., Lassmann, H., Otten, U., & Wekerle, H. (2001) · European Journal of Immunology · Cited by 159
Mechanisms of immunomodulation by glatiramer acetate
Gran, B., Tranquill, L. R., Chen, M., Bielekova, B., Zhou, W., Dhib–Jalbut, S., & Martin, R. (2000) · Neurology · doi:10.1212/wnl.55.11.1704 · Cited by 158
Teitelbaum, D., Fridkis‐Hareli, M., Arnon, R., & Sela, M. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(95)00180-8 · Cited by 153
Farina, C. (2001) · Brain · doi:10.1093/brain/124.4.705 · Cited by 112
Risk-Benefit Assessment of Glatiramer Acetate in Multiple Sclerosis
Ziemssen, T., Neuhaus, O., & Hohlfeld, R. (2001) · Drug Safety · doi:10.2165/00002018-200124130-00005 · Cited by 74
Self-citationCharacterization of T cell lines derived from glatiramer-acetate-treated multiple sclerosis patients
Qin, Y., Zhang, D. Q., Prat, A., Pouly, S., & Antel, J. P. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00263-0 · Cited by 68
Duda, P. W., Krieger, J. I., Schmied, M. C., Balentine, C., & Hafler, D. A. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.12.7300 · Cited by 68
Protection against Experimental Allergic Encephalomyelitis
Teitelbaum, D., Webb, C., Meshorer, A., Arnon, R., & Sela, M. (1972) · Nature · doi:10.1038/240564b0 · Cited by 37
Copolymer 1 from the laboratory to FDA.
Teitelbaum, D., Sela, M., & Arnon, R. (1997) · PubMed · Cited by 21
The Concept of Specific Immune Treatment Against Autoimmune Diseases
Sela, M. (1999) · International Reviews of Immunology · doi:10.3109/08830189909043025 · Cited by 19
Cited by
Polazzi, E., Mengoni, I., Caprini, M., Peña-Altamira, E., Kurtys, E., & Monti, B. (2013) · Neurosignals · doi:10.1159/000337115 · Cited by 8,994
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Kipnis, J., Cohen, H., Cardon, M., Ziv, Y., & Schwartz, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402268101 · Cited by 510
Type II monocytes modulate T cell–mediated central nervous system autoimmune disease
Weber, M. S., Prod'homme, T., Youssef, S., Dunn, S. E., Rundle, C. D., Lee, L., Patarroyo, J. C., Stüve, O., Sobel, R. A., Steinman, L., et al. (2007) · Nature Medicine · doi:10.1038/nm1620 · Cited by 447
Butovsky, O., Koronyo-Hamaoui, M., Kunis, G., Ophir, E., Landa, G., Cohen, H., & Schwartz, M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604681103 · Cited by 388
Metadata
- Authors
- Ziemssen, T.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-11-01
- Volume
- 125
- Issue
- 11
- Pages
- 2381-2391
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2161060662
- Cited by
- 268
- References
- 43
- FWCI
- 11.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.